期刊文献+

高效液相色谱法和紫外分光光度计法测定孕酮阴道环体外释药量的比较研究 被引量:3

Study on Comparing HPLC with UV to Determine the Release Quantity of Progesterone Vagina Ring in vitro
下载PDF
导出
摘要 目的:比较高效液相色谱(HPLC)法和紫外分光光度计(UV)法测定孕酮阴道环体外释药量。方法:①HPLC法:十八烷基键合硅胶为填充剂,以甲醇∶水(63∶37)为流动相,流速为1.0ml/min,检测波长254nm;②UV法:检测波长254nm。结果:UV法测定释药量均值为9.9μg/ml,相对标准偏差(RSD)4.82%;HPLC法测定释药量均值为10.1μg/ml,RSD2.25%。配对t检验统计结果表明HPLC和UV法的结果没有显著性差异。结论:两种方法均可作为体外释放量的测试方法。 Objective: To compare HPLC with UV to determined the release quantity of progesterone vagina ring in vitro. Methods: 1) HPLC: An ODS column and a mobile phase of methanol-water (63 : 37) were used. The flow rate was 1.0 ml/min and measuring wavelength was 254 nm; 2) UV:The measuring wavelength was 254 nm. Results: The mean of release quantity was 10.1 μg/ml, RSD was 2.25% by HPLC and the mean of release quantity was 9.9 μg/ml, RSD was 4.82% by UV. Conclusion: There is no remarkable difference between the results of HPLC and UV according statistic conclusion with partnership t test.Two methods can both be used to measure the release quantity of progesterone vagina ring in vitro.
出处 《生殖与避孕》 CAS CSCD 北大核心 2006年第9期546-549,553,共5页 Reproduction and Contraception
基金 国家十五科技攻关项目项目号:2004BA709B10
关键词 HPLC UV 孕酮阴道环 体外释药量 HPLC UV progesterone vagina ring release quantity in vitro
  • 相关文献

参考文献4

  • 1杨藻宸(上编).医用药理学.第2版.北京:人民卫生出版社,1986,p.603.
  • 2席尔德(著).周金黄(主译).应用药理学.北京:人民卫生出版社,1983,p.442.
  • 3Burton FG,Burton WE,Skiens WE,et al.Fabrication and testing of vaginal of contraceptive device designed for release of prespecified Dose levels of steroids.Contraception,1978,17(3):221-30.
  • 4国家药典委员会.中国药典(二部).2000年版.北京:化学工业出版社,2000,p.757-8.

共引文献1

同被引文献29

  • 1杨彦,温坚.米非司酮治疗子宫肌瘤的研究进展[J].医学理论与实践,2004,17(10):1142-1144. 被引量:17
  • 2戴星,刘洁,李爱青,方明,曾怡.米非司酮治疗子宫肌瘤的效果观察[J].实用临床医学(江西),2004,5(6):82-84. 被引量:3
  • 3杨藻宸.医用药理学-第2版.北京:人民卫生出版社,1986.p603.
  • 4H.O.席尔德(著),周金黄(主译)..应用药理学..北京:人民卫生出版社,,1983..p442..
  • 5Burton FG, Skiens WE, Gordon NR, et al. Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids. Contraception, 1978,17(3): 221-30.
  • 6国家药典委员会.中国药典(二部).2000年版.北京:化学工业出版社,2000.P.757-8.
  • 7ZALANYI S. Progesterone and ovulation[ J]. Eur J Obstet Gyne- col Reprod Bio,2001,95( 2 ) :152 - 159.
  • 8GEMZELL-DANIELSSON K,MARIONS L. MeChanisms of action of mifepristone and levonorgestrel when used for emergency con- traception [ J ]. Hum Reprod Update ,2004, ! 0 (4) : 341 - 348.
  • 9SPITZ IM. Progesterone antagonists and progesterone receptor modulators : an overview [ J ]. Steroids,2003,68 ( 10 - 13 ) : 981 -993.
  • 10EISINGER SH, FISCELLA J, BONFIGLIO T, et al. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata[J]. Eur J Obstet Gynecol Reprod Biol, 2009,146 (2) :215 -218.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部